These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2946308)

  • 1. Nicotinic acid or N-methyl nicotinamide prolongs elevated brain dopa and dopamine in L-dopa treatment.
    Black MJ; Brandt RB
    Biochem Med Metab Biol; 1986 Oct; 36(2):244-51. PubMed ID: 2946308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of L-dopa treatment on methylation in mouse brain: implications for the side effects of L-dopa.
    Liu XX; Wilson K; Charlton CG
    Life Sci; 2000; 66(23):2277-88. PubMed ID: 10855949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of benserazide on L-DOPA-derived extracellular dopamine levels and aromatic L-amino acid decarboxylase activity in the striatum of 6-hydroxydopamine-lesioned rats.
    Shen H; Kannari K; Yamato H; Arai A; Matsunaga M
    Tohoku J Exp Med; 2003 Mar; 199(3):149-59. PubMed ID: 12703659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of benserazide on the peripheral and central distribution and metabolism of levodopa after acute and chronic administration in the rat.
    Kent AP; Stern GM; Webster RA
    Br J Pharmacol; 1990 Aug; 100(4):743-8. PubMed ID: 2119841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L; Deng M; Zhang S; Fang Y; Li L
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of L-DOPA to the brain and reduces its O-methylation.
    Parada A; Loureiro AI; Vieira-Coelho MA; Hainzl D; Soares-da-Silva P
    Eur J Pharmacol; 2001 May; 420(1):27-32. PubMed ID: 11412836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subacute L-DOPA in mice: biochemical and behavioural effects.
    Jenkins O; Bailey R; Crisp E; Jackson DM
    Psychopharmacology (Berl); 1980; 68(1):77-83. PubMed ID: 6771801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592.
    Acquas E; Carboni E; de Ree RH; Da Prada M; Di Chiara G
    J Neurochem; 1992 Jul; 59(1):326-30. PubMed ID: 1613509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
    Eltayb A; Wadenberg ML; Svensson TH
    Biol Psychiatry; 2005 Aug; 58(4):337-43. PubMed ID: 16102547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
    Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
    Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic L-DOPA treatment of mice: a behavioural and biochemical study.
    Bailey R; Crisp E; Jackson DM; Jenkins O
    J Neural Transm; 1981; 50(2-4):209-24. PubMed ID: 6787171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase.
    Zhao WQ; Latinwo L; Liu XX; Lee ES; Lamango N; Charlton CG
    Exp Neurol; 2001 Sep; 171(1):127-38. PubMed ID: 11520127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of L-DOPA on brain serotonin metabolism related to tryptophan concentrations in plasma and brain of rats].
    Kohno Y
    Nihon Yakurigaku Zasshi; 1981 Mar; 77(3):281-93. PubMed ID: 6188670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain dialysis and dopamine: does the extracellular concentration of dopamine reflect synaptic release?
    Pani L; Gessa GL; Carboni S; Portas CM; Rossetti ZL
    Eur J Pharmacol; 1990 May; 180(1):85-90. PubMed ID: 2163865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of L-dopa on putrescine levels in the brain and the liver of the rat.
    Harik SI
    Eur J Pharmacol; 1979 Mar; 54(3):235-42. PubMed ID: 428424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
    Alachkar A; Brotchie JM; Jones OT
    Neurosci Res; 2010 Sep; 68(1):44-50. PubMed ID: 20542064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: on the role of benserazide pretreatment.
    Silva MA; Mattern C; Häcker R; Tomaz C; Huston JP; Schwarting RK
    Synapse; 1997 Dec; 27(4):294-302. PubMed ID: 9372552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo microdialysis to determine the relative pharmacokinetics of drugs.
    Nakashima M; Zhao MF; Nakashima MN; Sakurai M; Sasaki H; Matsuyama K; Ichikawa M
    Biol Pharm Bull; 1996 Jul; 19(7):988-94. PubMed ID: 8839975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats.
    Abercrombie ED; Bonatz AE; Zigmond MJ
    Brain Res; 1990 Aug; 525(1):36-44. PubMed ID: 2123121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the adenosine A2A receptor antagonist 8-(3-chlorostyryl)caffeine on L-DOPA biotransformation in rat striatum.
    Gołembiowska K; Dziubina A
    Brain Res; 2004 Feb; 998(2):208-17. PubMed ID: 14751592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.